Division of Gastroenterology and Hepatology, Kuang Tien General Hospital, Taichung 433, Taiwan.
World J Gastroenterol. 2013 Jan 21;19(3):321-7. doi: 10.3748/wjg.v19.i3.321.
Hepatoid adenocarcinoma (HAC) is a rare but important special type of extrahepatic adenocarcinoma with clinicopathological presentation mimicking hepatocellular carcinoma (HCC), and prompt and correct diagnosis can be a challenge, especially in endemic areas with a high incidence of HCC. To date, HAC has only been reported in case series or single case reports, so we aimed to review the clinicopathological characteristics of HAC to obtain a more complete picture of this rare form of extrahepatic adenocarcinoma. All the articles about HAC published from 2001 to 2011 were reviewed, and clinicopathological findings were extracted for analysis. A late middle-aged male with high serum α-fetoprotein and atypical image finding of HCC should raise the suspicion of HAC, and characteristic pathological immunohistochemical stains can help with the differential diagnosis. Novel immunohistochemical markers may be useful to clearly differentiate HAC from HCC. Once metastatic HAC is diagnosed, the primary tumor origin should be identified for adequate treatment. The majority of HAC originates from the stomach, so panendoscopy should be arranged first.
肝样腺癌(Hepatoid adenocarcinoma,HAC)是一种罕见但重要的肝外腺癌特殊类型,其临床表现类似于肝细胞癌(Hepatocellular carcinoma,HCC),因此及时、准确的诊断具有一定挑战性,尤其是在 HCC 发病率较高的流行地区。迄今为止,HAC 仅在病例系列或单个病例报告中有所报道,因此我们旨在回顾 HAC 的临床病理特征,以更全面地了解这种罕见的肝外腺癌。对 2001 年至 2011 年间发表的所有关于 HAC 的文章进行了回顾,并提取了临床病理发现进行分析。对于血清甲胎蛋白(α-fetoprotein,AFP)水平较高且 HCC 的影像学表现不典型的中老年男性,应高度怀疑 HAC,而特征性的病理免疫组织化学染色有助于鉴别诊断。新型免疫组织化学标志物可能有助于明确区分 HAC 和 HCC。一旦诊断为转移性 HAC,应确定原发肿瘤的来源,以便进行充分的治疗。大多数 HAC 来源于胃,因此应首先安排全内镜检查。